DEA warns prescription ADHD could be as bad as opioid crisis in scathing letter to pharmaceutical industry
The Drug Enforcement Administration (DEA) has expressed concern that the “aggressive marketing practices” of telehealth companies may be contributing to over-prescriptions of drugs used to treat attention deficit hyperactivity disorder (ADHD). , according to a letter from the agency. Although the letter does not mention specific companies, it is believed to refer to telehealth companies …